Asustek Computer Inc (華碩), the world’s No. 5 PC brand, yesterday said that it plans to introduce two more wearable devices in the second half of next year, seeking to repeat the success of the smartwatch it launched recently in a bid to become one of the world’s top three suppliers of wearable devices.
Asustek’s ZenWatch has been rolled out ahead of Apple Inc’s Apple Watch, which is expected to hit the market early next year.
“ZenWatch is our first wearable device powered by Goolge Inc’s Android Wear system,” Asustek chief executive Jerry Shen (沈振來) said at a product launch for the local market, following the smart device’s overseas debut.
Shen said the market reactions to the ZenWatch in the US and Japan have been satisfying. He declined to disclose sales figures.
“Select European countries, China and Hong Kong will be included in the second wave of ZenWatch launches,” he added.
The company said that supplies of the smart device are running short in the US and Japan, which Shen attributed to a components shortage.
Asustek only utilizes 50 percent of its 50,000 units-a-month capacity.
The supply shortage could extend to February next year, Shen said.
Despite this, Asustek is planning to launch the second-generation ZenWatch — which has a voice call function and a smart wristband — in the third quarter of next year.
Asustek hopes that the device, which is priced at NT$5,990, gains popularity in the mass market. That figure is almost half of Apple Watch’s price tag of at least US$349.
Since smartwatches are the first Internet of Things product with foreseeable growth potential, Asustek will strive to become “a key player” in this sector, Shen said.
The company is to boost ZenWatch production in the second half of next year, either to produce the first-generation models, or the second-generation ones, Shen said.
Separately, Shen said that “the weak yen has not affected the revenue ZenWatch has generated for Asustek because the product was launched in Japan in November and the currency appears to have stopped falling since then.”
Asustek’s share price closed down 0.88 percent at NT$337 yesterday, underperforming the TAIEX, which gained 0.97 percent.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining